F.D.A. Delays Clinical Trial of Embryonic Stem Cells
May 14th, 2008 at 8:29 pm (Drugs (Pharmaceuticals), Food and Drug Administration, Geron Corporation|GERN|NASDAQ, Stem Cells)
The Geron Corporation announced Wednesday that its plans to begin the first clinical trial using embryonic stem cells had been delayed by federal regulators.
Zrodlo (oryginalny wpis) na http://www.nytimes.com/2008/05/15/business/15stem.html?partner=rssnyt&emc=rss,By BLOOMBERG NEWS